New shot aims to stop cancer bone damage in its tracks
NCT ID NCT07028268
First seen Jan 05, 2026 · Last updated May 06, 2026 · Updated 14 times
Summary
This study tests an experimental drug called SHR-2017 in 210 adults with solid tumors that have spread to the bones. The goal is to see if it can reduce pain and prevent bone problems like fractures or the need for radiation or surgery. Participants will receive either SHR-2017 or an active comparator, and researchers will monitor pain scores and bone health markers over several weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOR PREVENTION OF BONE EVENTS IN PATIENTS WITH BONE METASTASES FROM SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, 510060, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.